Q1 EPS Forecast for Monopar Therapeutics Reduced by Analyst
Monopar Therapeutics Inc. (NASDAQ:MNPR – Free Report) – Equities researchers at HC Wainwright cut their Q1 2025 EPS estimates for shares of Monopar Therapeutics in a research note issued to investors on Tuesday, April 1st. HC Wainwright analyst S. Lee now forecasts that the company will earn ($0.44) per share for the quarter, down from […]
Monopar Therapeutics Inc. (NASDAQ:MNPR – Free Report) – Equities researchers at HC Wainwright cut their Q1 2025 EPS estimates for shares of Monopar Therapeutics in a research note issued to investors on Tuesday, April 1st. HC Wainwright analyst S. Lee now forecasts that the company will earn ($0.44) per share for the quarter, down from […]
